Opinion|Videos|April 7, 2025

How the Genetic Nature of Lp(a) Levels Influences Screening

Experts discuss the genetic determinants of lipoprotein(a) (Lp[a]) levels, providing evidence supporting this conclusion. They also explore how the hereditary nature of Lp(a) can drive awareness of atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis risk, potentially influencing screening protocols.

Video content above is prompted by the following:

  • I mentioned in the introduction that a person’s Lp(a) levels are mostly determined by genetics. What evidence supports this conclusion?
  • How might the hereditary nature of Lp(a) help drive awareness of risk for ASCVD and aortic stenosis and influence screening protocols?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo